Horio Y - Search Results

1

Risk factors for pneumonitis in patients with non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis.

Yamaguchi T, Shimizu J, Oya Y, Watanabe N, Hasegawa T, Horio Y, Inaba Y, Fujiwara Y. Yamaguchi T, et al. Among authors: horio y. Thorac Cancer. 2022 Mar;13(5):724-731. doi: 10.1111/1759-7714.14308. Epub 2022 Jan 19. Thorac Cancer. 2022. PMID: 35044093 Free PMC article.

2

Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.

Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R, et al. Horio Y, et al. Cancer Res. 1993 Jan 1;53(1):1-4. Cancer Res. 1993. PMID: 8380124

3

Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.

Horio Y, Hasegawa Y, Sekido Y, Takahashi M, Roth JA, Shimokata K. Horio Y, et al. Cancer Gene Ther. 2000 Apr;7(4):537-44. doi: 10.1038/sj.cgt.7700148. Cancer Gene Ther. 2000. PMID: 10811471

4

[Molecular targeted therapy--non-small-cell lung cancer and gefitinib].

Shimizu J, Horio Y, Mitsudomi T. Shimizu J, et al. Among authors: horio y. Gan To Kagaku Ryoho. 2005 Nov;32(12):1879-85. Gan To Kagaku Ryoho. 2005. PMID: 16282720 Review. Japanese.

5

Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer.

Yoshida K, Yatabe Y, Park JY, Shimizu J, Horio Y, Matsuo K, Kosaka T, Mitsudomi T, Hida T. Yoshida K, et al. Among authors: horio y. J Thorac Oncol. 2007 Jan;2(1):22-8. J Thorac Oncol. 2007. PMID: 17410005 Free article. Clinical Trial.

6

Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.

Sakamoto H, Shimizu J, Horio Y, Ueda R, Takahashi T, Mitsudomi T, Yatabe Y. Sakamoto H, et al. Among authors: horio y. J Pathol. 2007 Jul;212(3):287-94. doi: 10.1002/path.2165. J Pathol. 2007. PMID: 17534846

7

Chest wall dissemination of nocardiosis after percutaneous transthoracic needle biopsy.

Shimamoto H, Inaba Y, Yamaura H, Sato Y, Kamiya M, Miyazaki M, Arai Y, Horio Y. Shimamoto H, et al. Among authors: horio y. Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):797-9. doi: 10.1007/s00270-007-9002-0. Cardiovasc Intervent Radiol. 2007. PMID: 17659426

8

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines.

Shimizu J, Horio Y, Osada H, Hida T, Hasegawa Y, Shimokata K, Takahashi T, Sekido Y, Yatabe Y. Shimizu J, et al. Among authors: horio y. Respirology. 2008 Jun;13(4):510-7. doi: 10.1111/j.1440-1843.2008.01302.x. Respirology. 2008. PMID: 18494946

9

Epidermal growth factor receptor mutations in small cell lung cancer.

Tatematsu A, Shimizu J, Murakami Y, Horio Y, Nakamura S, Hida T, Mitsudomi T, Yatabe Y. Tatematsu A, et al. Among authors: horio y. Clin Cancer Res. 2008 Oct 1;14(19):6092-6. doi: 10.1158/1078-0432.CCR-08-0332. Clin Cancer Res. 2008. PMID: 18829487

10

Gefitinib for the treatment of non-small-cell lung cancer.

Hida T, Ogawa S, Park JC, Park JY, Shimizu J, Horio Y, Yoshida K. Hida T, et al. Among authors: horio y. Expert Rev Anticancer Ther. 2009 Jan;9(1):17-35. doi: 10.1586/14737140.9.1.17. Expert Rev Anticancer Ther. 2009. PMID: 19105704 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

392 results

Search Page

Filters